ABERRANT DISTRIBUTIONS OF NUCLEAR PORE COMPLEX PROTEINS IN ALS MICE AND ALS PATIENTS

作者：Shang Jingwei; Yamashita Toru; Nakano Yumiko; Morihara Ryuta; Li Xianghong; Feng Tian; Liu Xia; Huang Yong; Fukui Yusuke; Hishikawa Nozomi; Ohta Yasuyuki; Abe Koji^*

来源：Neuroscience, 2017, 350: 158-168.

DOI：10.1016/j.neuroscience.2017.03.024

• aberrant distribution
• amyotrophic lateral sclerosis
• human superoxide dismutase-1 transgenic mice
• nuclear pore complexes
• nucleoporin

Nuclear pore complexes (NPCs) play important roles in traffic of molecules between the nucleus and cytoplasm, aberrant distributions of components of NPCs were demonstrated in C9orf72 amyotrophic lateral sclerosis (C9-ALS) patients, but it is elusive whether such abnormities are also the case with other cause of ALS disease. In the present study, we investigated the spatiotemporal distributions of RanGAP1 and 4 representative nucleoporins (GP210, NUP205, NUP107 and NUP50) of NPCs in human Cu/Zn superoxide dismutase-1 mutation transgenic (SOD1-Tg) mice and sporadic ALS patients. Compared with wild type (WT), these proteins displayed age-dependent and progressive nuclear precipitations, and cytoplasmic aberrant expressions in motor neurons of lumbar cord in SOD1-Tg mice from 10 to 18 weeks (W). Double immunofluorescent analysis showed abnormal nuclear retention and apparent co-localizations of RanGAPI with NUP205 and NUP205 with NUP107, meanwhile, GP210 with NUP205 mainly co localized in the nuclear envelope (NE) of motor neurons. Furthermore, RanGAP1, GP210 and NUP50 showed similarly abnormal nuclear precipitations and cytoplasmic upregulations in SOD1-Tg mice and ALS patients, moreover, aberrant co-localizations of RanGAP1 with TDP-43 and NUP205 with TDP-43 were also observed in motor neurons. The present study indicated that the mislocalization of these proteins of NPCs may underlie the pathogenesis of ALS both in SOD1-Tg mice and human sporadic ALS patients, and these dysfunctions may be a fundamental pathway for ALS that is not specific only in C9-ALS but also in SOD1-ALS, which may be amenable to pharmacotherapeutic intervention.

• 出版日期2017-5-14